Alkaline phosphatase =< 2.5 x ULN (CTCAE v 3.0 grade 0-1)
Alkaline phosphatase within upper limits of institutional normal within 14 days prior to study entry
Alkaline phosphatase less than or equal to 2.5 x ULN (CTCAE grade 1)
Alkaline phosphate =< 3 x normal
Alkaline phosphatase =< 3 x ULN
Alkaline phosphatase =< 1.5 x IULN within 28 days prior to registration
Serum alkaline phosphatase (ALP) > 2 x ULN
Alkaline phosphatase less than or equal to 2.5 x ULN
Alkaline phosphatase =< 1.5 x institutional ULN, within 21 days prior to registration
Alkaline phosphatase (ALP) =< 2.5 x ULN measured within 28 days prior to randomization
Patients must have alkaline phosphatase =< 2.5 x IULN within 14 days prior to registration
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with known liver involvement and =< 7 x ULN for patients with known bone involvement)
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with known liver involvement and =< 7 x ULN for patients with known bone involvement)
Within 6 weeks prior to randomization: Alkaline phosphatase must be =< 2.5 x ULN for the lab
Albumin, alkaline phosphatase, bicarbonate, blood urea (BUN), chloride, glucose, phosphorus, and total protein must be assessed within 28 days of registration
Patients must have blood urea nitrogen (BUN), alkaline phosphatase, sodium, potassium, calcium, glucose, chloride, and bicarbonate levels obtained within 14 days prior to registration
Alkaline phosphatase =< 2.5 x ULN, within 14 days prior to registration
Alkaline phosphatase must be =< 3 x ULN for the lab within 28 days before randomization
Alkaline phosphatase =< 2.5 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)
Alkaline phosphatase =< 2 x IULN
Alkaline phosphatase =< 2.5 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)
Alkaline phosphatase =< 2.5 x ULN
Alkaline phosphatase =< 2.5 x ULN
Alkaline phosphatase =< 2.5 x IULN, obtained within 28 days prior to step 2 registration
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)